Lonza CD14+ Monocytes [positively selected]
Human CD14+ monocytes, isolated from mobilized peripheral blood using positive immunomagnetic selection, ≥ 10/ 25 million cells, cryopreserved.
Product Overview
Mobilized peripheral blood CD14+ monocytes are positively selected from mobilized peripheral blood MNC using a direct immunomagnetic CD14 microbeads labeling system. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols. Manufactured by AllCells®
Applications
Generate monocyte-derived M1 and M2 macrophages
Generate monocyte-derived DCs
Dendritic cell differentiation and maturation
Toll-like receptor and pattern recognition receptors (PRR)
Phagocytosis
Metabolism mechanisms
Content
1 vial containing ≥ 10/ 25 million cryopreserved cells
Recommended Media
Lonza X-VIVO™ 15 with L-glutamine, gentamicin, and phenol red
Lonza X-VIVO™ 15 Serum-free Hematopoietic Cell Medium, 500mL
Lonza X-VIVO™ 15 Serum-free Hematopoietic Cell Medium,1L
Lonza X-VIVO™ 15 with with L-glutamine, gentamicin, recombinant transferrin, and phenol red
Lonza X-VIVO™ 20 with L-glutamine, gentamicin and phenol red
Catalog #: 4Y-125 -- ≥25 million cells
Catalog #: 4Y-125A -- ≥10 million cells
Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.